Pharmacognosy intro
Olive Leaf's PRIMARY compound is oleuropein (6-9% dry leaf weight), a secoiridoid glycoside unique to the Oleaceae family, metabolized to hydroxytyrosol and elenolic acid. Hydroxytyrosol is one of the most potent natural antioxidants known, with ORAC values 10x vitamin C and 2x vitamin E. Additional compounds include tyrosol (less potent phenolic alcohol), verbascoside (anti-inflammatory, antimicrobial), luteolin and apigenin (anti-inflammatory flavones), oleocanthal (trace, structurally mimics ibuprofen via COX inhibition), and elenolic acid (antimicrobial). The PRIMARY mechanism is antioxidant: hydroxytyrosol and oleuropein inhibit LDL oxidation preventing atherosclerotic plaque formation, scavenge reactive oxygen species, and chelate pro-oxidant metals. The antihypertensive mechanism involves ACE inhibition and enhanced endothelial nitric oxide production with calcium channel-mediated smooth muscle relaxation, clinical evidence shows -11.45 mmHg systolic at 1000 mg/day. Anti-inflammatory activity involves dual inhibition of 5-LOX and 12-LOX (reducing leukotrienes) plus COX-2 inhibition, dual LOX/COX inhibition is pharmacologically rare. Elenolic acid disrupts microbial membranes and inhibits viral replication with broad-spectrum activity including MRSA. Metabolic effects include improved insulin sensitivity via AMPK activation and GLUT-4 translocation enhancement.